Two pharmaceutical companies are expanding the recent recalls of a variety of blood pressure medications. All of the recalls are due to the finding of N-Methylnitrosobutyric acid above the acceptable ...

High blood pressure is a serious concern, as health experts estimate it was either a “primary or contributing cause” for more than 664,000 deaths in 2023. But, as the Cleveland Clinic warns, ...

The reason differs from multiple other hypertension Rx recalls of late, according to a breaking FDA report.

Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP to the consumer level due to the ...